CPhI MEA 2018

Latest on Pharmaceutical Industry


FDA approves Bristol-Myers' Opdivo for small cell lung cancer

Bristol-Myers Squibb Co said on Friday the U.S. Food and Drug Administration approved its treatment, Opdivo, for patients whose lung cancer had progressed even after undergoing chemotherapy and at least one other therapy..Read More...

China-Based Adlai Nortye Opens Boston, Massachusetts, Biopharmaceutical Innovation Center

Adlai Nortye Ltd., a China-based globally-focused biopharmaceutical company dedicated to becoming a leader in developing effective therapies for cancer treatment and unmet medical needs, opened its first United States In..Read More...



12th Asian Biologics and Biosimilars Congress

Radisson Narita,
Conference Series LLC Ltd


2nd IPF Summit 2018

The Marker,
Hanson Wade

Press Releases

FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration

Regeneron Pharmaceuticals Inc today announced that the US Food and Drug Administration FDA has approved a supplemental Biologics License Application sBLA for EYLEA aflibercept Injection in patients with wet agerelated ma.. Read More...

FDA approves first generic version of EpiPen

The US Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr epinephrine autoinjector for the emergency treatment of allergic reactions including those that are lifethreatening ana.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Messe Muenchen India Pvt. Ltd.

Messe Muenchen India Pvt. Ltd. As per the World Bank India has made a substantial effort in attempting to address environmental challenges It has endorsed rigorous environmental legislation and has created relevant institutions to monitor and enforce legislation In response to the threat of climate change the Prime Ministers Nati. Read More...
Bhupinder Singh
Chief Executive Officer